Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
BioSpecifics Technologies Corp. to Present at Two Upcoming September Conferences
-
Corium to Present at Upcoming Healthcare Conferences
-
Iovance Biotherapeutics to Present at Two Upcoming September Conferences
-
AVEO Oncology to Present at Upcoming Conferences
-
Health Insurance Innovations (HIIQ) Weakness 'Overdone' - Cantor Fitzgerald
-
Yields rise on strong U.S. manufacturing data
-
Coherus BioSciences Management to Present at Three Investor Healthcare Conferences in September
-
Amazon.com (AMZN): Updating Model For Whole Foods - Cantor Fitzgerald
-
Cantor Fitzgerald Starts MedEquities Realty Trust (MRT) at Overweight
-
The Trade Desk, Inc. (TTD): White Ops Partnership Adds Fraud Blocking - Cantor
-
Fate Therapeutics to Present at Upcoming Investor Conferences
-
Cantor Fitzgerald Downgrades CRH Medical (CRHM) to Neutral
-
Atara Biotherapeutics to Participate in Three Upcoming Investor Conferences
-
Cantor Fitzgerald Starts Global Medical REIT (GMRE) at Overweight
-
SCYNEXIS to Present at Upcoming Investor Conferences
-
OPKO Health to Present at Upcoming September Conferences
-
Amarin Corp. (AMRN): Lawsuit Defends Marketshare - Cantor
-
Sunesis to Present at Upcoming Investor Conferences
-
Mersana Therapeutics to Participate in Investor Conferences in September
-
REGENXBIO to Present at Upcoming Investor Conferences
-
Enanta Pharmaceuticals to Present at Three Upcoming Investor Conferences
-
Kamada Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
MyoKardia to Present at Two Upcoming Investor Conferences in September
-
Syndax Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences
-
Karyopharm Therapeutics to Participate in Upcoming Investor Conferences
-
Bellicum Pharmaceuticals to Present at Three Healthcare Investor Conferences in September
-
Epizyme to Participate in Upcoming Investor Conferences
-
Mesoblast (MESO): Accelerated Approval Possible In 1Q18 - Cantor Fitzgerald
-
No Fundamental Reasons for Valeant (VRX) Weakness - Cantor Fitzgerald
-
Novartis CANTOS Study for ACZ885 Bodes Well for Amarin (AMRN) - Cantor Fitzgerald
-
Advisory Board Company (ABCO) PT Raised to $54 at Cantor Fitzgerald; 'Announces Sale of Business In Two Step Process'
-
Merit Medical to Participate at Five Conferences
-
Arena Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Cantor Fitzgerald Remains Bullish on HealthEquity (HQY) Ahead of 2Q Release
-
UPDATE: Cantor Fitzgerald Starts Jack Henry (JKHY) at Overweight
-
Fluidigm to Participate in Two Upcoming Health Care Conferences in September
-
Streetwise Reports Examines A Northern BC Explorer Offers 'One of the Lowest Market Caps per Ounce'
-
Halozyme Therapeutics To Present At Upcoming Healthcare Conferences
-
Cantor Fitzgerald Assumes WellCare Health Plans (WCG) at Overweight
-
LaVoieHealthScience Adds Former Analyst, Chiara Russo to Its Investor Relations Team
-
R1 RCM to Present at Two Upcoming Investor Conferences
-
Vocera to Present at Upcoming Investor Conferences
-
Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences
-
Snap (SNAP) Is Looking Better - Cantor
-
BioCryst to Present at Three Upcoming Investor Conferences
-
Tabula Rasa HealthCare to Participate in Upcoming Investor Conferences
-
Evolent Health to Participate in Upcoming Investor Conferences
-
Paratek Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences
-
Omeros Closes $68.3 Million Public Offering of Common Stock
-
Cantor Fitzgerald is Not Concerned About Shire (SHPG) CFO Departure

